(MedPage Today) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday.
FDA Commissioner Marty Makary…
Source link : https://www.medpagetoday.com/washington-watch/fdageneral/116121
Author :
Publish date : 2025-06-17 19:42:00
Copyright for syndicated content belongs to the linked Source.
